• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

mHealth (Mobile Health)

Ascensia Diabetes integrates its Eversense CGM with Apple Health

November 7, 2022 By Danielle Kirsh

Marketing image Senseonics Eversense E3 Ascensia Diabetes Care

  Ascensia Diabetes Care announced today that it has updated its Eversense Continuous Glucose Monitoring system app to integrate with Apple Health. The Parsippany, N.J.-based company makes the Contour Blood Glucose Monitoring (BGM) system and distributes Senseonics’ Eversense CGM system. The new Apple Health integration will allow people with diabetes using Senseonics’ Eversense CGM systems to […]

Filed Under: Diabetes, Featured, mHealth (Mobile Health) Tagged With: Ascensia Diabetes Care, Senseonics

BrightInsight raises $101M for its pre-built digital health platform

March 30, 2021 By Chris Newmarker

BrightInsight

BrightInsight announced today that it’s raised $101 million in a Series C round led by VC firm General Catalyst. The money will go toward more hiring and further accelerating the work BrightInsight is conducting with customers to support their digital health product launches. The San Jose, Calif.–based company offers a turnkey digital health platform for […]

Filed Under: Contract Services, Featured, Funding Roundup, mHealth (Mobile Health), Patient Monitoring, Research & Development Tagged With: BrightInsight, General Catalyst

Looking back at two decades of CGM advances

February 10, 2021 By Brian Buntz

FreeStyle Libre 2 from Abbott

Continuous glucose monitors (CGMs) have transformed how many people with diabetes manage blood sugar, but attempts to monitor blood glucose have a long history. Attempts to manage glucose kicked off in earnest when researchers began measuring glucose in urine in the mid-1800s. Scientists’ ability to do so steadily improved over the years, but urine glucose […]

Filed Under: Diabetes, Drug-Device Combinations, Food & Drug Administration (FDA), mHealth (Mobile Health) Tagged With: abbott, DexCom Inc., diabetes management, digital health, Eversense, FDA, Medtronic, mhealth, Senseonics

Teva Pharmaceuticals’ stock sinks 6.5% on Q3 results

November 5, 2020 By Brian Buntz

Teva

Teva (NYSE: TEVA) reported third-quarter results today that matched analysts’ consensus forecast. The company will maintain its guidance for the rest of the year. Teva, which has dual headquarters in Israel and Parsippany, N.J., reported a loss of -$4.3 billion or -$3.97 per share on revenue of $3.9 billion for the quarter ended September 30, […]

Filed Under: Drug-Device Combinations, mHealth (Mobile Health), Pharmaceuticals, Wall Street Beat Tagged With: COVID-19, Kare Schultz, Teva

Tandem Diabetes Care acquires Sugarmate mobile app

June 24, 2020 By Chris Newmarker

Tandem Diabetes Care Sugarmate

Tandem Diabetes Care (NSDQ:TNDM) said today that it has purchased Sugarmate — as mobile app that helps people better manage their diabetes. Financial terms of the deal were not disclosed. Nearly 30,000 people relying on insulin pumps or multiple daily injections presently use the Sugarmate app. Sugarmate cofounder Josh Juster will join Tandem as a VP […]

Filed Under: Diabetes, Featured, mHealth (Mobile Health) Tagged With: Sugarmate, Tandem Diabetes Care

Insulet’s Omnipod Dash Personal Diabetes Managers have a glitch

February 13, 2020 By Chris Newmarker

Insulet Ominipod Dash Personal Diabetes Managers

Insulet (NSDQ:PODD) is issuing a voluntary medical device correction for all of the smartphone-like Personal Diabetes Managers that came with its next-gen Omnipod Dash insulin management system, the company announced today. During its ongoing quality management process, Insulet officials discovered that the PDMs on rare occasions will suggest an inaccurate bolus amount based on a blood […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Recalls Tagged With: Insulet, insulin

How connected health can optimize patient and provider experience

November 21, 2019 By Chris Newmarker

Phillips-Medisize connected drug delivery devices

Connected drug-delivery devices provide quantitative data on medication uses that may improve patient engagement and a move toward value-based payments. Iain Simpson, Phillips-Medisize Healthcare has become increasingly digitalized in the past decade, with the widespread adoption of electronic health records (EHR), connected devices in hospitals and laboratories, and smartphones and tablets to support healthcare professionals. […]

Filed Under: Drug-Device Combinations, Featured, mHealth (Mobile Health)

Log Pharma Packaging launches smart packaging

November 5, 2019 By Sean Whooley

Log Pharma Packaging said today that it is launching its ActiveGuard Connect smart packaging solutions. ActiveGuard Connect is designed to address the lack of patient adherence to prescription medicine or supplementation of nutraceuticals. It is comprised of an integrated desiccant chamber designed to link and synchronize with a patient’s smartphone. The smart packaging product enables […]

Filed Under: Business/Financial News, Featured, mHealth (Mobile Health), Patient Monitoring Tagged With: Log Pharma Packaging

Bayer leads One Drop’s $40m Series B, inks deal to expand past diabetes

September 17, 2019 By Brad Perriello

Bayer gets in on One Drop

Bayer (ETR:BAYN) led a $40 million Series B round for glucose monitor maker One Drop, licensed its platform for treating conditions beyond diabetes and put its pharma president on the One Drop board. New York City-based One Drop developed a compact blood glucose monitor, pairing it with an app designed to provide behavioral cues and one-on-one coaching. […]

Filed Under: Diabetes, Featured, Funding Roundup, mHealth (Mobile Health) Tagged With: Bayer AG, One Drop

Senseonics touts BCBS reimbursement wins

September 4, 2019 By Sarah Faulkner

Senseonics - updated logo

Senseonics (NYSE:SENS) said today that Blue Cross Blue Shield of Massachusetts and Idaho now provide coverage for the implantable Eversense continuous glucose monitor. The company’s Eversense device includes a fluorescence-based sensor, a mobile app and a transmitter. Senseonics’ touts its system as being the first with a long-term, implantable CGM sensor, as well as the first […]

Filed Under: Business/Financial News, Diabetes, Featured, mHealth (Mobile Health), Wall Street Beat Tagged With: Senseonics

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 8
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS